COSCIENS Biopharma Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2016 | $-29.0M | $-29.1M | $66.0K | $31.0K |
| FY2017 | $-22.9M | $-22.9M | $4.0K | $95.0K |
| FY2018 | $6.8M | $6.8M | $9.0K | $108.0K |
| FY2019 | $-10.7M | $-10.7M | — | — |
| FY2020 | $-4.1M | $-4.1M | — | $61.0K |
| FY2021 | $-8.6M | $-8.6M | $30.0K | $311.0K |
| FY2022 | $5.2M | $4.9M | $304.0K | $3.4M |
| FY2023 | $-2.6M | $-3.3M | $722.0K | $3.9M |
| FY2024 | $-14.6M | $-15.7M | $1.2M | $5.2M |
| FY2025 | $-8.5M | $-9.2M | $706.0K | $6.4M |